Patents by Inventor Bruno Provstgaard Nielsen

Bruno Provstgaard Nielsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11930838
    Abstract: An oral pouched product is disclosed, the pouched product comprising a saliva permeable pouch and a pouch composition, the pouch composition comprising a powdered composition, water, and a liquid flavor composition, wherein the liquid flavor composition is added to the powdered composition after the water. A further oral pouched product and a method of manufacturing an oral pouched product is disclosed.
    Type: Grant
    Filed: June 5, 2020
    Date of Patent: March 19, 2024
    Assignee: PHILIP MORRIS PRODUCTS S.A.
    Inventors: My Ly Lao Stahl, Heidi Ziegler Bruun, Bruno Provstgaard Nielsen, Jesper Neergaard, Bine Hare Jakobsen
  • Publication number: 20240000706
    Abstract: A water-dissolvable compressed oral nicotine lozenge is disclosed, the oral nicotine lozenge comprising a first module and a second module, the first and the second modules being fused by compression, the first module being a lozenge module comprising at least one sugar alcohol and the second module being an FDT-module comprising at least one sugar alcohol and nicotine. Also, a method of manufacturing a water-dissolvable compressed oral nicotine lozenge is disclosed.
    Type: Application
    Filed: August 3, 2023
    Publication date: January 4, 2024
    Applicant: Fertin Pharma A/S
    Inventors: Dorthe Schackinger Boesen, Heidi Ziegler Bruun, Bruno Provstgaard Nielsen, Kent Albin Nielsen, Rikke Pranger-Rasmussen
  • Publication number: 20240000713
    Abstract: A water-dissolvable nicotine tablet is disclosed, the nicotine tablet comprising at least a first compressed module and a second compressed module, wherein the first compressed module is an FDT-module and comprises nicotine, alkaline pH regulating agent, and disintegrant, and, wherein the second compressed module is a lozenge-module and comprises acidic pH regulating agent. Also, a method of manufacturing a nicotine tablet is disclosed.
    Type: Application
    Filed: September 11, 2023
    Publication date: January 4, 2024
    Applicant: Fertin Pharma A/S
    Inventors: Kent Albin Nielsen, Rikke Pranger-Rasmussen, Dorthe Schackinger Boesen, Heidi Ziegler Bruun, Bruno Provstgaard Nielsen
  • Patent number: 11805802
    Abstract: A nicotine pouch composition is disclosed, the pouch composition includes at least one sugar alcohol, at least one water-insoluble fiber, water in an amount of 8-65% by weight of the composition, and nicotine. Also, an oral pouched nicotine product and a method for manufacturing an oral pouched product is disclosed.
    Type: Grant
    Filed: June 5, 2020
    Date of Patent: November 7, 2023
    Assignee: PHILIP MORRIS PRODUCTS S.A.
    Inventors: My Ly Lao Stahl, Heidi Ziegler Bruun, Bruno Provstgaard Nielsen, Jesper Neergaard, Bine Hare Jakobsen
  • Publication number: 20230346768
    Abstract: The invention relates to an orally disintegrating nicotine tablet for nicotine craving relief comprising a pressed powder formulation, the tablet being designed to disintegrate within a period of less than 60 seconds upon oral administration, the powder formulation comprising an amount of nicotine and a pH regulating agent.
    Type: Application
    Filed: July 7, 2023
    Publication date: November 2, 2023
    Applicant: Fertin Pharma A/S
    Inventors: Bruno Provstgaard Nielsen, Kent Albin Nielsen
  • Patent number: 11786473
    Abstract: A water-dissolvable nicotine tablet is disclosed, the nicotine tablet comprising at least a first compressed module and a second compressed module, wherein the first compressed module is an FDT-module and comprises nicotine, alkaline pH regulating agent, and disintegrant, and, wherein the second compressed module is a lozenge-module and comprises acidic pH regulating agent. Also, a method of manufacturing a nicotine tablet is disclosed.
    Type: Grant
    Filed: December 14, 2021
    Date of Patent: October 17, 2023
    Assignee: Fertin Pharma A/S
    Inventors: Kent Albin Nielsen, Rikke Pranger-Rasmussen, Dorthe Schackinger Boesen, Heidi Ziegler Bruun, Bruno Provstgaard Nielsen
  • Patent number: 11759419
    Abstract: A water-dissolvable compressed oral nicotine lozenge is disclosed, the oral nicotine lozenge comprising a first module and a second module, the first and the second modules being fused by compression, the first module being a lozenge module comprising at least one sugar alcohol and the second module being an FDT-module comprising at least one sugar alcohol and nicotine. Also, a method of manufacturing a water-dissolvable compressed oral nicotine lozenge is disclosed.
    Type: Grant
    Filed: October 11, 2019
    Date of Patent: September 19, 2023
    Assignee: Fertin Pharma A/S
    Inventors: Dorthe Schackinger Boesen, Heidi Ziegler Bruun, Bruno Provstgaard Nielsen, Kent Albin Nielsen, Rikke Pranger-Rasmussen
  • Patent number: 11738016
    Abstract: The invention relates to an orally disintegrating nicotine tablet for nicotine craving relief comprising a pressed powder formulation, the tablet being designed to disintegrate within a period of less than 60 seconds upon oral administration, the powder formulation comprising an amount of nicotine and a pH regulating agent.
    Type: Grant
    Filed: December 7, 2018
    Date of Patent: August 29, 2023
    Assignee: Fertin Pharma A/S
    Inventors: Bruno Provstgaard Nielsen, Kent Albin Nielsen
  • Publication number: 20230218512
    Abstract: The present invention relates in a first aspect to a fast disintegrating cannabinoid tablet, the tablet comprising a sugar alcohol composition comprising one or more sugar alcohol particles in an amount of at least 20% by weight of the tablet, a cannabinoid composition comprising one or more cannabinoids, and a disintegrant composition comprising one or more disintegrants operable to disintegrate the tablet within a period of 2 minutes or less in contact with oral saliva. In a second aspect, the invention relates to a modular tablet, wherein the tablet comprises a further tablet module that is different in composition.
    Type: Application
    Filed: February 27, 2023
    Publication date: July 13, 2023
    Inventors: Heidi Ziegler Bruun, Dorthe Schackinger Boesen, Bruno Provstgaard Nielsen
  • Publication number: 20230181478
    Abstract: A water-dissolvable nicotine tablet is disclosed, the nicotine tablet comprising at least a first compressed module and a second compressed module, wherein the first compressed module is an FDT-module and comprises nicotine, alkaline pH regulating agent, and disintegrant, and, wherein the second compressed module is a lozenge-module and comprises acidic pH regulating agent. Also, a method of manufacturing a nicotine tablet is disclosed.
    Type: Application
    Filed: December 14, 2021
    Publication date: June 15, 2023
    Applicant: Fertin Pharma A/S
    Inventors: Kent Albin Nielsen, Rikke Pranger-Rasmussen, Dorthe Schackinger Boesen, Heidi Ziegler Bruun, Bruno Provstgaard Nielsen
  • Publication number: 20230158011
    Abstract: The invention relates to an oral nicotine formulation for use in the alleviation of nicotine craving, the formulation comprising a content of nicotine and a content of a pH regulating agent, wherein the formulation provides a peak saliva concentration of nicotine of more than 0.3 mg/mL and a peak saliva pH of more than 7.5 during the first 120 seconds upon oral administration.
    Type: Application
    Filed: December 7, 2018
    Publication date: May 25, 2023
    Applicant: Fertin Pharma A/S
    Inventors: Bruno Provstgaard Nielsen, Kent Albin Nielsen
  • Patent number: 11633351
    Abstract: The present invention relates in a first aspect to a fast disintegrating cannabinoid tablet, the tablet comprising a sugar alcohol composition comprising one or more sugar alcohol particles in an amount of at least 20% by weight of the tablet, a cannabinoid composition comprising one or more cannabinoids, and a disintegrant composition comprising one or more disintegrants operable to disintegrate the tablet within a period of 2 minutes or less in contact with oral saliva. In a second aspect, the invention relates to a modular tablet, wherein the tablet comprises a further tablet module that is different in composition.
    Type: Grant
    Filed: December 13, 2019
    Date of Patent: April 25, 2023
    Inventors: Heidi Ziegler Bruun, Dorthe Schackinger Boesen, Bruno Provstgaard Nielsen
  • Patent number: 11540557
    Abstract: A nicotine pouched product is disclosed, the nicotine pouched product having a pouch composition and a pouch membrane enclosing the pouch composition, the pouch composition including at least one water-insoluble fiber, water in an amount of at least 15% by weight of the composition, and nicotine, wherein the pouch membrane comprises further nicotine in an amount of at least 15% by weight of a total content of nicotine in the pouched product.
    Type: Grant
    Filed: June 5, 2020
    Date of Patent: January 3, 2023
    Assignee: Philip Morris Products S.A.
    Inventors: My Ly Lao Stahl, Heidi Ziegler Bruun, Bruno Provstgaard Nielsen, Bine Hare Jakobsen
  • Publication number: 20220322727
    Abstract: An oral pouched product is disclosed, the oral pouched product includes a saliva permeable pouch, a non-tobacco pouch composition, the pouch composition includes heat-treated fibers, nicotine in an amount of 0.1-5.0% by weight of the pouch compositions, water in an amount 15-65% by weight of the pouch composition, at least one sugar alcohol, and less than 0.5% preservative by weight of the pouch composition. Also, a method for manufacturing an oral pouched product is disclosed.
    Type: Application
    Filed: June 23, 2022
    Publication date: October 13, 2022
    Inventors: My Ly Lao Stahl, Heidi Ziegler Bruun, Bruno Provstgaard Nielsen, Jesper Neergaard, Bine Hare Jakobsen
  • Patent number: 11399562
    Abstract: An oral pouched product is disclosed, the oral pouched product includes a saliva permeable pouch, a pouch composition, the pouch composition includes heat-treated fibers, nicotine, water in an amount of less than 65% by weight of the pouch composition, and at least one sugar alcohol. Also, a method for manufacturing an oral pouched product is disclosed.
    Type: Grant
    Filed: June 5, 2020
    Date of Patent: August 2, 2022
    Assignee: NCP NextGen A/S
    Inventors: My Ly Lao Stahl, Heidi Ziegler Bruun, Bruno Provstgaard Nielsen, Jesper Neergaard, Bine Hare Jakobsen
  • Publication number: 20220087929
    Abstract: An oral pouched product is disclosed, the oral pouched product includes a saliva permeable pouch, a pouch composition, the pouch composition includes heat-treated fibers, nicotine, water in an amount of less than 65% by weight of the pouch composition, and at least one sugar alcohol. Also, a method for manufacturing an oral pouched product is disclosed.
    Type: Application
    Filed: June 5, 2020
    Publication date: March 24, 2022
    Applicant: NCP NextGen A/S
    Inventors: My Ly Lao Stahl, Heidi Ziegler Bruun, Bruno Provstgaard Nielsen, Jesper Neergaard, Bine Hare Jakobsen
  • Publication number: 20220039455
    Abstract: An oral pouched product is disclosed, the pouched product comprising a saliva permeable pouch and a pouch composition, the pouch composition comprising a powdered composition, water, and a liquid flavor composition, wherein the liquid flavor composition is added to the powdered composition after the water. A further oral pouched product and a method of manufacturing an oral pouched product is disclosed.
    Type: Application
    Filed: June 5, 2020
    Publication date: February 10, 2022
    Applicant: NCP NextGen A/S
    Inventors: My Ly Lao Stahl, Heidi Ziegler Bruun, Bruno Provstgaard Nielsen, Jesper Neergaard, Bine Hare Jakobsen
  • Publication number: 20210345656
    Abstract: The invention relates to an oral nicotine formulation for use in the alleviation of nicotine craving, the formulation comprising a content of nicotine and a content of a pH regulating agent, wherein the formulation is designed for the content of nicotine to dissolve in the oral saliva within a period of less than 90 seconds upon oral administration, and wherein at least 40% by weight of the nicotine is absorbed through the oral mucosa.
    Type: Application
    Filed: December 7, 2018
    Publication date: November 11, 2021
    Applicant: Fertin Pharma A/S
    Inventors: Bruno Provstgaard Nielsen, Kent Albin Nielsen
  • Publication number: 20210329962
    Abstract: A nicotine pouch composition is disclosed, the pouch composition comprising free-base nicotine and having a water content of at least 15% by weight of said pouch composition. Furthermore, an oral nicotine pouch product comprising the pouch composition and a method for manufacturing the oral nicotine pouch product is disclosed.
    Type: Application
    Filed: July 8, 2021
    Publication date: October 28, 2021
    Inventors: My Ly Lao Stahl, Heidi Ziegler Bruun, Bruno Provstgaard Nielsen, Bine Hare Jakobsen
  • Publication number: 20210307375
    Abstract: A nicotine pouch composition is disclosed, the pouch composition includes at least one sugar alcohol, at least one water-insoluble fiber, water in an amount of 8-65% by weight of the composition, and nicotine. Also, an oral pouched nicotine product and a method for manufacturing an oral pouched product is disclosed.
    Type: Application
    Filed: June 5, 2020
    Publication date: October 7, 2021
    Inventors: My Ly Lao STAHL, Heidi Ziegler BRUUN, Bruno Provstgaard NIELSEN, Jesper NEERGAARD, Bine Hare JAKOBSEN